Calculated socio-economic damage due to perioperative iron deficiency or iron deficiency anemia (ID/IDA) is 6.2 thousand years of life and 3.1 billion rubles. Hence, it is necessary to develop approaches to the most appropriate methods to assess the possible socio-economic benefits of preoperative ID/IDA correction in Russia.

OBJECTIVE

Based on several coloproctological diseases (C18, C19—C21, class II ICD 10) to conduct a quantitative model assessment of the socio-economic damage/benefits and calculate some financial and economic indicators in the context of differentiated outcomes of operations due to the non-use/use of patient blood management (PBM).

MATERIALS AND METHODS

We analyzed 250 randomly selected medical records of patients operated on for malignant neoplasms of the colon and rectum at the A.N. Ryzhikh «of the Ministry of Health of Russia in 2019.

RESULTS

Patients with colorectal cancer and IDA stay in the hospital longer than patients without anemia (OR=1.51; 0.91—2.49; 95%), with the difference the more significant, the more pronounced the anemia (from 1, 2 to 5.1 days, p<0.005). Therefore, the potential implementation of PBM in coloproctology will save 46.5 million rubles or 2.4 million rubles per 1.000 operated patients with concomitant anemia.

CONCLUSIONS

PBM implementation in coloproctology can reduce losses by more than four times. Evaluation of PBM in the context of cost/effectiveness will provide a new perspective on managing patients with perioperative ID/ IDA. It will undoubtedly accelerate the introduction of PBM as an approach that enhances the clinical effectiveness and cost-effectiveness of surgical interventions.